NHSE968 - Greater Manchester - Diabetic Eye Screening Programme

Location

Manchester

Description

It is the intention of NHS England/NHS Greater Manchester Integrated Care Partnership the (Relevant Authority) to award the Greater Manchester Diabetic Eye Screening Programme from 01 April 2026 for a period of 2-years with the option of a further 1-year extension period at the discretion of the Relevant Authority and subject to satisfactory contractual and financial performance under the Direct Award Process C of the PSR 2023, subject to the Relevant Authority being of the opinion that, the existing provider, is satisfying the existing contract and will likely be able to satisfy the new contract to a sufficient standard taking into account relevant key criteria and basic selection criteria.

CPV Codes

• 85100000 - Health services

Other Information

This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Regulations 2024 (Procurement Act 2023) and/ or Public Contracts Regulations 2015 do not apply to this award. This contract has now been formally awarded using Direct Award Process C. Contract Start Date: 01 April 2026 Contract End Date: 31 March 2029 Contract Value: 17933453 GBP Details of the individual(s) making the award decision: NHS Greater Manchester - Primary Care Contract Committee. Public Health Manager (Commissioning) - NHSEngland/NHS Greater Manchester Integrated Care Partnership. Public Health Commissioning Manager - NHSEngland/NHS Greater Manchester Integrated Care Partnership. Assistant Head of Finance (Direct Commissioning) -NHS England/NHS Greater Manchester Health and Social Care Partnership. The existing provider is satisfying the existing contract and will likely satisfy the new contract. The provider has been assessed and passed against the relevant 5 key criteria and mandatory requirements. There were no conflicts of interests identified.